Contains two or more isomerized compounds, N as isomerized cyclic isomers, GPR119 toxicants and DPP-IV inhibitors; pharmacological components; used in the treatment of type II diabetes, obesity, metabolic Sindrome, glucose degradation tolerance and high fat Among other diseases

摘要

Heterocyclic compounds containing two or more heteroatoms such as n Heterocycles with CycleGPR119 agonists and Inhibitors of DPP IV, Pharmaceutical Composition and its use in the treatment of Type II diabetes, obesity, metabolic syndrome,Impaired tolerance to glucose and hyperlipidemia, among other diseases.